Artesunate–amodiaquine for the treatment of uncomplicated malaria

Bibliography

• ROGIER C, TRAPE JF: Malaria: organizations, network and new initiatives. Med. Trop. (Mars) (1999) 59(Suppl. 2):55-56.
   PubMedGoogle Scholar
• SNOW RW, CRAIG M, DEICHMANN U, MARSH K: Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. World Health Organ. (1999) 77(8):624-640.
   PubMed Web of Science ®Google Scholar
• ROWE AK, ROWE SY, SNOW RW et al.: The burden of malaria mortality among African children in the year 2000. Int. J. Epidemiol. (2006) 35(3):691-704.
   PubMed Web of Science ®Google Scholar
• WHO: Global malaria control strategy. Bull. Pan. Am. Health Organ. (1993) 27(3):280-283.
   Google Scholar
• TINTO H, ZOUNGRANA EB, COULIBALY SO et al.: Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998 – 2000. Trop. Med. Int. Health (2002) 7(11):925-930.
   PubMed Web of Science ®Google Scholar
• PIETRA V, LAMIZANA L, DEL NERO L, ROTIGLIANO G: In vivo chemosensitivity of Plasmodium falciparum to chloroquine in Burkina Faso: development of resistance 1988 – 1990. Parassitologia (1992) 34(1-3):131-134.
   PubMedGoogle Scholar
• OGWANG S, ENGL M, VIGL M, KOLLARITSCH H, WIEDERMANN G, WERNSDORFER WH: Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda. Wien. Klin. Wochenschr. (2003) 115(Suppl. 3):45-49.
   PubMed Web of Science ®Google Scholar
• WHITE NJ, OLLIARO P: Artemisinin and derivatives in the treatment of uncomplicated malaria. Med. Trop. (Mars) (1998) 58(Suppl. 3):54-56.
   PubMedGoogle Scholar
• WHITE NJ, PONGTAVORNPINYO W: The de novo selection of drug-resistant malaria parasites. Proc. Biol. Sci. (2003) 270(1514):545-554.
   PubMed Web of Science ®Google Scholar
• SIRIMA SB, TIONO AB, KONATE A et al.: Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial. Trans. R. Soc. Trop. Med. Hyg. (2003) 97(3):345-349.
   PubMed Web of Science ®Google Scholar
• MAKANGA M, PREMJI Z, FALADE C et al.: Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Am. J. Trop. Med. Hyg. (2006) 74(6):991-998.
   PubMed Web of Science ®Google Scholar
• ASHLEY EA, KRUDSOOD S, PHAIPHUN L et al.: Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J. Infect. Dis. (2004) 190(10):1773-1782.
   PubMed Web of Science ®Google Scholar
• ASHLEY EA, LWIN KM, MCGREADY R et al.: An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Trop. Med. Int. Health. (2006) 11(11):1653-1660.
   PubMed Web of Science ®Google Scholar
• VON SEIDLEIN L, MILLIGAN P, PINDER M et al.: Efficacy of artesunate plus pyrimethamine–sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 355(9201):352-357.
   PubMed Web of Science ®Google Scholar
• BRASSEUR P, AGNAMEY P, CISSE M et al.: Artesunate (AS) plus amodiaquine (AQ) for treating falciparum malaria – assessing its efficacy and tolerability during six years of field deployment in Southern Senegal. Abstracts of the American Society of Tropical Medicine and Hygiene 55th Annual Meeting, Atlanta (12 – 16 November 2006). Am. J. Trop. Med. Hyg. (2006) 75(Suppl. 5):306 (Abstract).
   Google Scholar
• LUO XD, SHEN CC: The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med. Res. Rev. (1987) 7(1):29-52.
   PubMed Web of Science ®Google Scholar
• BETHELL DB, TEJA-ISAVADHARM P, CAO XT et al.: Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1997) 91(2):195-198.
   PubMed Web of Science ®Google Scholar
• SKINNER TS, MANNING LS, JOHNSTON WA, DAVIS TM: In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int. J. Parasitol. (1996) 26(5):519-525.
   PubMed Web of Science ®Google Scholar
• TER KUILE F, WHITE NJ, HOLLOWAY P, PASVOL G, KRISHNA S: Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. (1993) 76(1):85-95.
   PubMed Web of Science ®Google Scholar
• BARRADELL LB, FITTON A: Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs (1995) 50(4):714-741.
   PubMed Web of Science ®Google Scholar
• TAYLOR WR, WHITE NJ: Antimalarial drug toxicity: a review. Drug Saf. (2004) 27(1):25-61.
   PubMed Web of Science ®Google Scholar
• DAYAN AD: Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use? Med. Trop. (Mars) (1998) 58(Suppl. 3):32-37.
   PubMedGoogle Scholar
• GORDI T, LEPIST EI: Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol. Lett. (2004) 147(2):99-107.
   PubMed Web of Science ®Google Scholar
• CLARK RL, WHITE TE, CLODE AS, GAUNT I, WINSTANLEY P, WARD SA: Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res. B. Dev. Reprod. Toxicol. (2004) 71(6):380-394.
   PubMed Web of Science ®Google Scholar
• KRISHNA S, WHITE NJ: Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin. Pharmacokinet. (1996) 30(4):263-299.
   PubMed Web of Science ®Google Scholar
• BRASSEUR P, GUIGUEMDE R, DIALLO S et al.: Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Trans. R. Soc. Trop. Med. Hyg. (1999) 93(6):645-650.
   PubMed Web of Science ®Google Scholar
• GRANDESSO F, BACHY C, DONAM I et al.: Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad. Trans. R. Soc. Trop. Med. Hyg. (2006) 100(5):419-426.
   PubMed Web of Science ®Google Scholar
• MUTABINGWA TK, ANTHONY D, HELLER A et al.: Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet (2005) 365(9469):1474-1480.
   PubMed Web of Science ®Google Scholar
• GUTHMANN JP, AMPUERO J, FORTES F et al.: Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans. R. Soc. Trop. Med. Hyg. (2005) 99(7):485-492.
   PubMed Web of Science ®Google Scholar
• KROGSTAD DJ, GLUZMAN IY, KYLE DE et al.: Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science (1987) 238(4831):1283-1285.
   PubMed Web of Science ®Google Scholar
• OLLIARO P, MUSSANO P: Amodiaquine for treating malaria. Cochrane Database Syst. Rev. (2003) 2:CD000016.
   Google Scholar
• HATTON CS, PETO TE, BUNCH C et al.: Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 1(8478):411-414.
   Google Scholar
• BERNUAU J, LARREY D, CAMPILLO B et al.: Amodiaquine-induced fulminant hepatitis. J. Hepatol. (1988) 6(1):109-112.
   PubMed Web of Science ®Google Scholar
• NEFTEL KA, WOODTLY W, SCHMID M et al.: Amodiaquine-induced agranulocytosis and liver damage. Br. Med. J. (Clin. Res. Ed.) (1986) 292(6522):721-723.
   PubMed Web of Science ®Google Scholar
• WOODTLI W, VONMOOS P, SIEGRIST P et al.: Amodiaquine-induced hepatitis with leukopenia. Schweiz Med. Wochenschr. (1986) 116(29):966-968.
   PubMedGoogle Scholar
• LARREY D, CASTOT A, PESSAYRE D et al.: Amodiaquine-induced hepatitis. A report of seven cases. Ann. Intern. Med. (1986) 104(6):801-803.
   PubMed Web of Science ®Google Scholar
• OLLIARO P, NEVILL C, LEBRAS J et al.: Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet (1996) 348(9036):1196-1201.
   PubMed Web of Science ®Google Scholar
• CHATTERJEE T, MUHKOPADHYAY A, KHAN KA, GIRI AK: Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine. Mutagenesis (1998) 13(6):619-624.
   PubMed Web of Science ®Google Scholar
• WHITE NJ, NOSTEN F, LOOAREESUWAN S et al.: Averting a malaria disaster. Lancet (1999) 353(9168):1965-1967.
   PubMed Web of Science ®Google Scholar
• WHITE NJ: Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia (1999) 41(1-3):301-308.
   PubMedGoogle Scholar
• WHITE NJ, OLLIARO PL: Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol. Today (1996) 12(10):399-401.
   PubMedGoogle Scholar
• SOWUNMI A, BALOGUN T, GBOTOSHO GO et al.: Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children. Antimicrob. Agents Chemother. (2007) 51(5):1694-1699.
   PubMed Web of Science ®Google Scholar
• PRICE RN, NOSTEN F, LUXEMBURGER C et al.: Effects of artemisinin derivatives on malaria transmissibility. Lancet (1996) 347(9016):1654-1658.
   PubMed Web of Science ®Google Scholar
• OLLIARO P, VAILLANT M, PHALKEY R et al.: Artesunate + amodiaquine (AS+AQ) for the treatment of uncomplicated falciparum malaria: an inventory of clinical studies and systematic review of safety and efficacy data. Abstracts of the American Society of Tropical Medicine and Hygiene 55th Annual Meeting, Atlanta (12 – 16 November 2006) Am. J. Trop. Med. Hyg. (2006) 75(Suppl. 5):7 (Abstract).
   Google Scholar
• DURRANI N, LESLIE T, RAHIM S, GRAHAM K, AHMAD F, ROWLAND M: Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan. Trop. Med. Int. Health (2005) 10(6):521-529.
   PubMed Web of Science ®Google Scholar
• ADJUIK M, AGNAMEY P, BABIKER A et al.: Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet (2002) 359(9315):1365-1372.
   PubMed Web of Science ®Google Scholar
• BARENNES H, NAGOT N, VALEA I et al.: A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. Trop. Med. Int. Health (2004) 9(4):438-444.
   PubMed Web of Science ®Google Scholar
• KORAM KA, ABUAKU B, DUAH N, QUASHIE N: Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. (2005) 95(3):194-203.
   PubMed Web of Science ®Google Scholar
• SOWUNMI A, FEHINTOLA FA, ADEDEJI A et al.: Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Trop. Med. Int. Health (2005) 10(11):1161-1170.
   PubMed Web of Science ®Google Scholar
• MARTENSSON A, STROMBERG J, SISOWATH C et al.: Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin. Infect. Dis. (2005) 41(8):1079-1086.
   PubMed Web of Science ®Google Scholar
• MEREMIKWU M, ALARIBE A, EJEMOT R et al.: Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Malar. J. (2006) 5:43.
   PubMed Web of Science ®Google Scholar
• GRANDESSO F, HAGERMAN A, KAMARA S et al.: Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. Trop. Med. Int. Health (2006) 11(7):1017-1021.
   PubMed Web of Science ®Google Scholar
• CHECCHI F, RODDY P, KAMARA S et al.: Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine–pyrimethamine and amodiaquine. Trop. Med. Int. Health (2005) 10(2):146-153.
   PubMed Web of Science ®Google Scholar
• YEKA A, BANEK K, BAKYAITA N et al.: Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. (2005) 2(7):e190.
   PubMed Web of Science ®Google Scholar
• TINTO H, RWAGACONDO C, KAREMA C et al.: In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. Trans. R. Soc. Trop. Med. Hyg. (2006) 100(6):509-514.
   PubMed Web of Science ®Google Scholar
• GORISSEN E, ASHRUF G, LAMBOO M et al.: In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Trop. Med. Int. Health (2000) 5(6):459-463.
   PubMed Web of Science ®Google Scholar
• STAEDKE SG, KAMYA MR, DORSEY G et al.: Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet (2001) 358(9279):368-374.
   PubMed Web of Science ®Google Scholar
• RWAGACONDO CE, KAREMA C, MUGISHA V et al.: Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Trop. Med. Int. Health (2004) 9(10):1091-1098.
   PubMed Web of Science ®Google Scholar
• AUBOUY A, MAYOMBO J, KEUNDJIAN A, BAKARY M, LE BRAS J, DELORON P: Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro tests. Am. J. Trop. Med. Hyg. (2004) 71(3):294-296.
   PubMed Web of Science ®Google Scholar
• ZONGO I, DORSEY G, ROUAMBA N et al.: Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. Am. J. Trop. Med. Hyg. (2005) 73(5):826-832.
   PubMed Web of Science ®Google Scholar
• WHITE NJ: Why is it that antimalarial drug treatments do not always work? Ann. Trop. Med. Parasitol. (1998) 92(4):449-458.
   PubMed Web of Science ®Google Scholar
• LI XQ, BJORKMAN A, ANDERSSON TB, RIDDERSTROM M, MASIMIREMBWA CM: Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. J. Pharmacol. Exp. Ther. (2002) 300(2):399-407.
   PubMed Web of Science ®Google Scholar
• WANG SJ, LENGELER C, SMITH A et al.: Rapid urban malaria appraisal (RUMA) I: epidemiology of urban malaria in Ouagadougou. Malar. J. (2005) 4:43.
   Google Scholar
• SIRIMA SB, TIONO AB, GANSANÉ A et al.: A randomised trial comparing efficacy and safety of artesunate-amodiaquine given as Combined or individual therapies for the treatment of acute, uncomplicated Plasmodium falciparum malaria in children in Burkina Faso. Abstracts of the 5th European Congress on Tropical Medicine and International Health, Amsterdam, the Netherlands (24 – 28 May 2007). Trop. Med. Int. Health (2007) 12(s1):1-274 (Abstract O27-71).
   PubMedGoogle Scholar
• THOMAS F, ERHART A, D’ALESSANDRO U: Can amodiaquine be used safely during pregnancy? Lancet Infect. Dis. (2004) 4(4):235-239.
   PubMed Web of Science ®Google Scholar
• TAGBOR H, BRUCE J, BROWNE E et al.: Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet (2006) 368(9544):1349-1356.
   PubMed Web of Science ®Google Scholar
• MASSAGA JJ, KITUA AY, LEMNGE MM et al.: Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet (2003) 361(9372):1853-1860.
   PubMed Web of Science ®Google Scholar